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Abstract
Background: Shb, a ubiquitously expressed Src homology 2 domain-containing adaptor protein has previously
been implicated in the signaling of various tyrosine kinase receptors including the TCR. Shb associates with SLP76,
LAT and Vav, all important components in the signaling cascade governing T cell function and development. A
Shb knockout mouse was recently generated and the aim of the current study was to address the importance of
Shb deficiency on T cell development and function.
Results: Shb knockout mice did not display any major changes in thymocyte development despite an aberrant
TCR signaling pattern, including increased basal activation and reduced stimulation-induced phosphorylation. The
loss of Shb expression did however affect peripheral CD4+ TH cells resulting in an increased proliferative response
to TCR stimulation and an elevated IL-4 production of naïve TH cells. This suggests a TH2 skewing of the Shb
knockout immune system, seemingly caused by an altered TCR signaling pattern.
Conclusion: Our results indicate that Shb appears to play an important modulating role on TCR signaling, thus
regulating the peripheral CD4+ TH2 cell response.
Background
The primary aim of T cell development is to create a
fully competent T lymphocyte population in the periph-
ery, capable of quickly identifying pathogens yet non-
responsive to self-tissue [1,2]. To maintain this delicate
balance, the immature thymocytes are subjected to rig-
orous control, where signaling through the T cell recep-
tor (TCR) is of utmost importance [3-5]. Mature,
peripheral T cells are equally dependent on the TCR, as
activation and effector cell development are decided by
TCR signaling strength and duration [6-8].
Upon receptor engagement, a host of adaptor and
effector proteins assemble at numerous phosphotyro-
sines within the cytoplasmic segment of the TCR signal-
ing complex. Among the key players in this signaling
system are the adaptors SLP76 [9,10] and linker for acti-
vation of T cells (LAT) [11,12], their association with
the activated TCR and their subsequent phosphorylation
that activates signaling through phospholipase C-g
(PLC-g) [13], as well as Ras and the Rho family of
GTPases [14,15], which in turn enable activation of
more distal pathways such as the various variants of
mitogen activated kinases (MAPKs) [16-18]. Loss of
early signaling elements, such as LAT or SLP76 there-
fore has profound effects on T cell development and
function, with an almost complete block at the very first
thymocyte development step requiring TCR signaling,
the b- selection, and with severely impaired peripheral
responses as a consequence [11,19-21].
Shb is a widely expressed adaptor protein, known to
associate with a variety of different tyrosine kinases,
including receptors important for hematopoiesis in gen-
eral and lymphopoiesis in particular, including the acti-
vated TCR, VEGFR- 2 and PDGFR [22-24]. In the case
of TCR signaling, the SH2-domain of Shb binds to the
ζ-chain of the CD3 complex, where it partakes in the
LAT- SLP76 signaling complex [24,25]. Shb has been
demonstrated to associate with both LAT and SLP76,
and to facilitate the phosphorylation of numerous down-
stream signaling targets such as Vav-1 and PLC-g,
accordingly playing an important role in proper TCR
signal transduction [24-26].* Correspondence: michael.welsh@mcb.uu.se
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A Shb knockout mouse has recently been generated.
No viable Shb knockout offspring could be generated on
the C57Bl/6 background owing to an early embryonic
defect. However Shb null mice were obtained on a
mixed background (129Sv/C57Bl6/FVB) [27]. The ani-
mals display abnormalities in their reproduction, vascu-
lature and glucose homeostasis [27-30]. We employed
the Shb knockout to assess thymus and T cell function.
Although early T cell development appears unaffected,
we observe hyperproliferation and a skewing towards a
TH2 response in peripheral T cells.
Methods
Animals
The generation of Shb knockout mice has been
described previously [27]. The animals were bred on a
mixed background (129Sv/C57Bl6/FVB). All experi-
ments were approved by the local animal ethics commit-
tee at Uppsala University.
Cell preparation
Freshly isolated thymi and spleens were gently crushed
through a 70 μm cell strainer (BD Bioscience, Erembo-
degem, Belgium) and thereafter treated with Red cell
lysis buffer (Sigma Aldrich, St. Lois, MO) in order to
remove erythrocytes.
Flow cytometry
For flow cytometry 1 × 106 cells in a final volume of 100
μl 1% BSA in PBS were stained with the following anti-
bodies CD4-FITC, CD8-FITC, CD4-PE-Cy5, CD8- PE,
CD44-PE-Cy5, CD25-PE, and CD62L-PE (all antibodies
were purchased from eBioscience, Hartfield, UK). Flow
cytometry was performed on a FACSCalibur (BD
Bioscience) using CellQuest software (BD Bioscience,
Franklin Lakes, NJ).
TCR stimulation
Single cell suspensions with 1 × 107 thymocytes or 1 ×
106 splenocytes in RPMI 1640 (Gibco, Paisley, UK) sup-
plemented with 10% FBS and 50 μM b-mercaptoethanol
(Sigma Aldrich) were stimulated with CD3-antibody
(BD Bioscience) at a concentration of 10 μg/ml in 37°C.
Thymocytes were stimulated for either 2 or 5 minutes
whereas splenocytes were stimulated for 2 minutes.
Immunoprecipitation and immunoblotting
Cell lysates were prepared by addition of lysis buffer (20
mMTris -HCl pH 7.8, 150 mM NaCl, 2 mM EDTA, 1%
Triton X- 100, 2 mM PMSF, 10 μg/L aprotinin and 10
μg/L leupeptin). Immunoprecipitation was performed by
incubating the samples with either a-phosphotyrosine
antibody (Millipore, Watford, UK) or with Shb antibody
[31] at 0.5 μg/ml or 5 μg/ml, respectively, for 1 hour at
4°C. This was followed by incubation with Protein A
sepharose (GE Healthcare, Uppsala, Sweden) under the
same conditions. Samples were washed 3 times in lysis
buffer and resuspended in SDS-sample buffer.
Protein denaturation was achieved by boiling the sam-
ples for 5 minutes followed by separation on SDS-
PAGE. Proteins were transferred to Hybond-P mem-
branes (GE Healthcare) and subsequently blocked in 5%
BSA over night at 4°C.Immunodetection The membranes
were probed with the following antibodies: a-phospho-
tyrosine (Millipore), phospho-ERK (Cell Signaling Tech-
nology), PLCg (Milipore), c-Cbl (BD Bioscience), Vav1
(Millipore), phospho-p38 (Cell Signaling Technology),
ZAP70 (BD Bioscience), p38 (Cell Signaling Technol-
ogy), Shb and ERK (Cell Signaling Technology). Immu-
nodetection was performed using HRP-conjugated
secondary antibodies (GE Healthcare) and ECL detec-
tion solution (GE healthcare) according to manufac-
turer’s instructions. The autoradiographic film (GE
healthcare) was afterwards exposed to the membrane for
2 seconds up to 2 minutes, depending on the strength of
the signal.
T cell purification, proliferation and cytokine production
assay
Single cell suspensions of splenocytes were fractioned
into either CD4+ or CD8+ cells or into naïve CD4+
cells using MACS magnetic microbeads (Miltenyi
Biotec, Bergisch Gladbach, Germany), following the
manufacturer’s instructions. 5 × 105 CD4+ or CD8+
splenocytes were plated on 24-well plates precoated
with 2.5 μg/ml a-CD3 and 3 μg/ml a-CD28 antibodies
(BD Bioscience) in a volume of 1.5 ml F-DMEM (SVA,
Uppsala, Sweden) supplemented with 10% FBS and 50
μM b-mercaptoethanol. Supernatants were harvested
every 24 hours for 6 days and cytokine production was
estimated by sandwich immunoassays using Gyrolab
Bioaffy (Gyros Biotech, Uppsala, Sweden) following the
manufacturer’s instructions [32]. On the fourth day of
stimulation, 10% of the cells were incubated with 1 μCi
of 3H-thymidine (GE Healthcare) 4 hours, in order to
estimate proliferative activity. The amount of radioactiv-
ity was thereafter determined with a Wallac 1409 scintil-
lation counter (Perkin Elmer, Waltham, MA, USA).
Naïve CD4+ cells were cultured under the same condi-
tions as described above, but the cells were plated on
96-well plates at a concentration of 5 × 104 cells per
well in 200 μl for 2 day cultures and 2.5 × 104 cells per
well for 3 to 5 day cultures.
Real-time reverse transcription- PCR
RNA was isolated from naïve CD4+ cells, at the indicated
time points, using a RNAeasy mini kit (Qiagen, Solna,
Sweden) following the manufacturer’s instructions. Gene
Gustafsson et al. BMC Immunology 2011, 12:3
http://www.biomedcentral.com/1471-2172/12/3
Page 2 of 10
expression was quantified using the SYBR® Green RT-
PCR kit (Qiagen). PCR conditions were 50°C for 20 min-
utes and 95°C for 15 minutes, followed by 45 cycles with
denaturation at 94°C for 15 seconds, annealing for 25
seconds at the various temperatures indicated in table 1
and extension at 72°C for 15 seconds. Primer sequences
are listed in table 1. Transcription levels were normalized
against b-actin. All PCR reactions were run on a Light
Cycler (Roche Diagnostics, Basel, Switzerland) and CT-
values were calculated using the accompanying software.
Cell cycle analysis
The cell cycle status of naïve CD4+ T cells was analyzed
at the indicated time points by adding 5-bromo-2-deox-
yuridine (BrdU) (Sigma Aldrich) in a final conctration of
50 μM followed by a 2-hour incubation. The cells were
subsequently fixed and permeabilized using the BD
Cytofix/Cytoperm kit (BD Bioscience) following the
instructions provided by the manufacturer. Cell cycle
status was determined by staining with anti-BrdU-APC
(Invitrogen Ltd, Paisley, UK) and 7-amino-actinomyocin
D (7AAD) (eBioscience) followed by analysis on a
FACSCalibur (BD Bioscience) using CellQuest software
(BD Bioscience).
Statistical analysis
Data is presented as mean ± Standard error of the mean
(SEM). For comparison of difference between two
groups with normal distributed data, unpaired Students
t-tests were used unless otherwise stated. For paired
comparisons, one wild type and one age and sex
matched knockout sample was analyzed simultaneously,
under identical conditions, and the wild type and the
knockout values were set as one observation each for
the comparison. All p-values less than 0.05 were consid-
ered statistically significant.
Results
Effect of Shb null allele on blood cell numbers
Since Shb has been demonstrated to interact with the
TCR, but also with other receptors that are important
for the development and function of the hematopoietic
system it was of interest to determine whether the loss
of Shb expression would result in any alterations in the
number of blood cells. Hematocrit values and thrombo-
cyte numbers appeared unchanged (data not shown),
whereas both lymphocyte (WT 6.6 ± 0.42 million cells/
ml; KO 4.6 ± 1.2 million cells/ml) and monocyte (WT
0.21 ± 0.05 million cells/ml; KO 0.07 ± 0.02 million
cells/ml) numbers were decreased in the Shb knockout
(lympocytes p < 0.01; monocytes p < 0.05) (Figure 1).
Aberrant signal transduction in Shb knockout thymocytes
TCR signaling is of uttermost importance in thymocyte
development as many of the survival and death signals
are mediated through the receptor. Peripheral lymphocyte
numbers may therefore be adversely affected by a disrup-
tion of signaling during early thymocyte development. To
explore this possibility further, wild type and knockout
thymocytes were stimulated for 2 and 5 minutes, fol-
lowed by immunoprecipitation with phosphotyrosine
antibody. This revealed alterations in important TCR sig-
naling components. PLC-g phosphorylation was lowered
after both 2 and 5 minutes of stimulation in the Shb
knockout (Figure 2) whereas Vav-1 and Cbl display
increased basal phosphorylation levels in knockout thy-
mocytes. Additionally, Shb knockout thymocytes fail to
mount any stimulation-induced increase of Vav-1 and
Cbl phosphorylation (Figure 2). A similar pattern is
observed when the corresponding lysastes were probed
for tyrosine phosphorylations; two major phosphotyrosine
Table 1 PCR primer sequences and Tm used for the RT-
PCR analysis
Primers Sequence (5’-3’) Tm
Beta-actin 5’ CAC TAT TTG GCA ACG AGC GG 60°C
Beta-actin 3’ TCC ATA CCC AAG AAG GAA GGC 60°C
IL-2 5’ TTG AGT GCC AAT TCG ATG ATG 55°C
IL-2 3’ AGA TGA TGC TTT GAC AGA AGG CTA 55°C
IL-4 5’ CGG AGA TGG ATG TGC CAA AA 60°C
IL-4 3’ GCA CCT TGG AAG CCC TAC AG 60°C
IFN-g 5’ CCT GGG GCC TAG CTC TGA 60°C
IFN-g 3’ CAG CCA GGA ACA GCC ATG AG 60°C
GATA3 5’ CGA GAT GGT ACC GGG CAC TA 60°C
GATA3 3’ GAC AGT TCG CGC AGG ATG 60°C
Tbet 5’ TTC CCA TTC CTG TCC TTC ACC 60°C
Tbet 3’ TGC CTT CTG CCT TTC CAC AC 60°C
????????????????
??
Figure 1 Peripheral blood profile. Peripheral blood was stained
with May-Grünwald Giemsa in order to quantify leukocyte numbers
(n = 8, mean ± SEM, ** denotes p < 0,01, * denotes p < 0,05 by
Students t-test).
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proteins of 65 and 50 kDa both display elevated basal
phosphorylation levels but no stimulation effect (Figure
2). Other studies performed on Shb knockout endothelial
cells and oocytes, have demonstrated elevated signaling in
the absence of ligand-stimulation, suggesting this as being
a feature in common in several signaling systems lacking
Shb [28,30]. ZAP70 phosphorylation was unaffected by
the absence of Shb, which is an expected finding since
Shb is predicted to operate downstream of ZAP70 in the
TCR signaling pathway (Figure 2). Moreover, extracellular
signal regulated kinase (ERK) signaling, which has been
implicated in positive selection [33,34], appeared similar
in the two groups of cells after both 2 and 5 minutes of
stimulation (Figure 2).
Unaltered thymocyte development in the Shb knockout
mouse
Since thymocytes exhibited a changed signaling pattern
in response to TCR stimulation, thymi were isolated
from mice 3 weeks of age, as thymocyte developmental
activity is at a peak at this time [35]. Thymocyte num-
bers were determined, but no distinguishable differences
between knockout and wild type animals were observed
(Figure 3A). Even though there was no detectable devia-
tion in thymocyte numbers, relative changes in the
proportions of different developmental subsets in the
thymus could cause the reduced numbers of lympho-
cytes in peripheral blood. Thymocytes were therefore
stained for CD4 and CD8 in order to identify the differ-
ent developmental stages [36,37]. However, Shb knock-
out animals displayed no statistically significant changes
in the relative numbers of double positive (DP), single
positive (SP) CD4+, and SP CD8+ cells (Figure 3B).
Thymocytes were also analyzed for CD44 and CD25
expression to enable a distinction between the different
double negative (DN) subsets [5], but the Shb knockout
mice displayed no major differences in the DN1-4 popu-
lations (each given in percent of the total DN popula-
tion) (Figure 3C).
Figure 2 Thymocyte stimulation response. Thymocytes were
stimulated with CD3-antibody for 2 and 5 minutes and analyzed by
either immunoprecipitation with phosphotyrosine antibody followed
by Western blot or by just performing Western blot on cell lysates.
Blots were probed for phosphotyrosine, phospho-PLCg, phospho-Vav,
phospho-Zap70, phospho-Cbl, phospho-ERK, Cbl, ERK and Shb.
?
?
?
Figure 3 Thymocyte maturation in mice 3 weeks of age. (A) The
number of thymocytes was determined by Bürker chamber
counting (n = 9, mean ± SEM). (B) Thymocytes stained with
fluorescent CD4 and CD8 antibodies and analyzed with flow
cytometry (n = 9, mean ± SEM). (C) Thymocytes were isolated and
stained with fluorescent antibodies directed against CD4, CD8, CD25
and CD44 and analyzed with flow cytometry (n = 9, mean ± SEM).
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Shb knockout TH cells display altered signaling and
proliferation
Despite changes in the TCR response to stimulation
observed in Shb knockout thymocytes, knockout mice
exhibited no major changes in central T cell develop-
ment. This prompted us instead to evaluate peripheral
T cell function. We first analyzed absolute numbers of
splenocytes, yet no detectable difference between knock-
out and wild type animals was noted (Figure 4A).
To further study the function of peripheral T cells,
splenocytes were fractionated into CD4+ TH cells and
CD8+ TK cells and stimulated with CD3 and CD28 anti-
bodies for 96 hours after which proliferation was assessed
by estimating 3H thymidine incorporation. When com-
pared to the wild type cells, the Shb null CD4+ cells
exhibited a modest proliferation increase in response to
stimulation (WT 70 ± 9; KO 98 ± 2; p < 0.05) (Figure
4B). CD8+ Shb knockout cells also displayed a slightly
elevated proliferative response, although this effect did
not reach statistical significance (Figure 4B).
An increased proliferative rate is likely to be caused by
changes in TCR signal transduction. T cell signaling was
consequently examined by stimulating CD4+ TH cells
with CD3 antibody for 2 minutes. In immunodetection
with phosphotyrosine antibody the Shb knockout samples
displayed an overall increased protein phosphorylation in
the absence of stimulation (Figure 4C), a pattern similar
to what was observed in thymocytes. More specifically
there was a difference between wild type and knockout
in the phosphorylation of a 150 kDa band under basal
conditions as well as in stimulated cells (Figure 4C). In
addition, bands of molecular weights 120 kDa, 100 kDa
and 36/38 kDa exhibited a higher degree of phosphory-
lation in unstimulated Shb knockout samples, but
phosphorylation levels did not appear to increase with
stimulation.
In order to address the effect on other signaling path-
ways downstream of Shb, ERK and p38 MAPK activity
was measured in the samples, as both are important for
T cell survival and function. p38 MAPK stimulation was
poor in the knockout, partly as a consequence of
increased basal signal, whereas there was a clear increase
in the amount of phospho-p38 MAPK in the wild type
after stimulation (Figure 4C). ERK signaling on the
other hand seemed normal (Figure 4C).
TH2 skewing in Shb knockout T cells after stimulation
Another important factor governing T cell proliferation
is IL-2, a potent T cell mitogen [38]. To test whether
altered cytokine production was also a part of the
increased proliferation seen in Shb knockout TH cells,
cytokine levels were monitored every 24 hours for up to
Figure 4 Peripheral T cell signaling and proliferation. (A) The number of splenocytes was estimated by counting cells in a Bürker chamber (n
= 10, mean ± SEM). (B) Splenocytes were separated into CD4+ and CD8+ cells and stimulated for 96 hours with CD3- and CD28 antibodies.
Radioactively labeled thymidine was added for the last 4 hours to estimate proliferative activity. The proliferation data is presented as a
percentage of the highest value in each experiment that for CD4+ cells corresponds to 264326 ± 41432 and for CD8+ cells to 191290 ± 49852
DPM (n = 10, mean ± SEM, * denotes p < 0,05 by paired Students t-test). (C) CD4+ splenocytes were stimulated for 2 minutes with CD3
antibody and subsequently analyzed by Western blot. The samples were probed with phosphotyrosine,- phospho- p38-, phospho-ERK- and ERK
antibodies.
Gustafsson et al. BMC Immunology 2011, 12:3
http://www.biomedcentral.com/1471-2172/12/3
Page 5 of 10
5 days. Shb knockout T cells were found not to produce
more IL-2 than their wild type counterparts but rather
less, although this difference failed to reach statistical
significance (Figure 5A). IFN-g and IL-4 production
were also investigated, revealing increased levels of IL-4
in the Shb null samples at both 72 to 96 hours and at
96 to 120 hours (72-96 h WT 15 ± 5.4, KO 33 ± 12; 96-
120 h WT 62 ± 14, KO 93 ± 7; 72-96 h p < 0.05, 96-120
h p < 0.05) (Figure 5B). IFN-g levels were however simi-
lar in knockout and wild type (Figure 5C).
IL-4 is the hallmark cytokine of a TH2 response and
increased IL-4 levels is indicative of a bias towards TH2
driven immune response [39]. A TH2 skewing in combi-
nation with hyperproliferation often coincides with an
increase in the proportion of peripheral memory T cells
[21,40]. Memory and naïve T cells are distinguished by
their differential expression of CD44 and CD62L
[41,42], Shb knockout and wild type T cells were conse-
quently stained for these markers in order to determine
if knockout mice had higher levels of memory cells.
However, no difference in the proportions of memory
and naïve T cells was noted between knockout and wild
type animals (Figure 6A).
To further confirm that Shb knockout CD4+ TH cells
have a tendency to develop a type 2 cytokine response,
naïve CD4+CD62L+ T cells were isolated and stimu-
lated. BrdU incorporation and 7AAD staining revealed
that naïve knockout T cells appear to progress faster
through the cell cycle when stimulated, as demonstrated
by the modest but consistent increased percentage (p <
0.05) of Shb knockout cells in the later stages of the cell
cycle at 72 and 96 hours of stimulation (72 h WT 43 ±
5%, KO 48 ± 4%; 96 h WT 32 ± 2%, KO 36 ± 1%) (Fig-
ure 6B and 6C). Additionally, when cell numbers were
determined at the given time points the relative increase
in cell numbers were higher in Shb knockout samples
compared to the wild type (72 h WT 1.7 ± 0.5 fold
increase, KO 2.4 ± 0.5 fold increase; 96 h WT 2.4 ± 0.6
fold increase, KO 4.0 ± 0.7 fold increase; 120 h WT 3.1
± 0.8 fold increase, KO 6.0 ± 2.0 fold increase, all com-
pared with the starting number of cells; 72 h p < 0.01,
96 h p < 0.05, 120 h p < 0.01).
Since Shb null naïve T cells also exhibited a lympho-
proliferative phenotype we decided to assay cytokine
production in CD4+CD62L+ T cells after TCR stimula-
tion. Levels of mRNA revealed that IL-2 was produced
in similar amounts in knockout and wild type cells (Fig-
ure 7A). IL-4 gene expression was elevated at all
recorded time points but only reached statistical signifi-
cance at 72 and 120 hours (72 h WT 4.1 ± 0.68, KO 6.2
± 0.40; 92 h WT 6.2 ± 0.90, KO 9.0 ± 1.3; 120 h WT
7.3 ± 1.2; KO 9.4 ± 1.5, 72 h p < 0.05, 120 h p < 0.05).
The differences in CT-values correspond to an increase
of the Shb KO IL-4 mRNA levels compared with WT to
470 ± 110% and 230 ± 20% at 72 and 120 h, respectively
(Figure 7B). IFN-g levels were on the other hand similar
in knockout and wild type samples (Figure 7C).
The differentiation of a newly activated T cell into a
TH2 or a TH1 cell is governed by the transcription fac-
tors GATA3 and T-bet, respectively [43,44]. To further
ascertain whether the Shb knockout displays a TH2
skewing the expression of these transcription factors
was studied. The lack of Shb resulted in an elevated
expression of GATA3 after 120 hours of stimulation
(120 h WT 4.4 ± 2.2, KO 6.4 ± 1.6; p < 0.05) (Figure
7D) whereas T-bet levels appeared unaffected (Figure
7E). The altered CT-value corresponds to a 17.7 ± 8.5
fold increase in GATA3 mRNA in the Shb KO.
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Figure 5 TH cell profile in unfractionated CD4+ T lymphocytes
in response to stimulation. All cytokine data is presented as a
percentage of the highest value (given in ng/ml) in each
experiment and measured using the Gyros system. (A) The 100
percent IL-2 value corresponds to 9,2 ± 3,2 ng/ml (n = 8, mean ±
SEM). (B) The 100 percent IL-4 value corresponds to 10 ± 3 ng/ml (n
= 8, mean ± SEM, * denotes p < 0,05 by paired Students t-test). (C)
The 100 percent IFN-g value corresponds to 130 ± 38 ng/ml (n = 5,
mean ± SEM).
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Discussion
We have previously demonstrated the involvement of
the adaptor protein Shb in TCR signal transduction in
Jurkat cells. The current study expands these observa-
tions by examining T cell development and T cell func-
tion in a Shb knockout mouse. Our data establish that
Shb is dispensable for thymocyte development but that
it exerts effects on peripheral CD4+ T cell signaling.
Consequently, unfractionated CD4+ and purified naïve
T cells proliferate at a higher rate. An increased number
of memory T cells is most probably not the cause of the
Shb knockout phenotype since no difference in the pro-
portions of memory and naïve CD4+ T cells was noted
48%
16%25%
11%40%
14%32%
15%
?? ??
?
?
?
?
*
*
**
**
*
Figure 6 Naïve and memory CD4+ T cell profile. (A) Isolated
splenocytes were stained for CD4, CD62L and CD44 in order to
identify naïve and memory T cells (n = 6, mean ± SEM). (B, C) Naïve
CD4+CD62L+ T cells were isolated and stimulated for 72, 96 or 120
hours followed by 2 hours of BrdU-pulse labeling. Cell cycle status
was subsequently assessed based on BrdU and 7AAD staining. Plots
represent typical experiment (n = 6, mean ± SEM, * denotes p <
0.05 by paired Students t-test). (D) The numbers of stimulated naïve
CD4+CD62L+ T cells were determined at the indicated time points
and related to the initial numbers of cells plated to determine
relative increase in cell numbers (n = 6, mean ± SEM, * denotes p <
0.05, ** denotes p < 0.01 by paired Students t-test).
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Figure 7 TH cell gene expression profile in unfractionated
naïve CD4+CD62L+ T lymphocytes in response to TCR
stimulation. (A, B, C) Transcript levels of cytokines IL-2, IL-4 and IFN-
g were determined by semiquantitative RT-PCR and normalized
against the expression of the house keeping gene b-actin. Data is
presented as 20 minus the mean of the normalized CT values ±
SEM. (n = 6, ** denotes p < 0,01 by paired Students t-test). (B, C, D)
Relative expression of the transcription factors GATA3 and T-bet
were estimated through a semiquantitative RT-PCR and normalized
against the expression of the house keeping gene b-actin. GATA3 is
presented as 30 minus the mean of the normalized CT values and
Tbet as 20 minus the mean of the normalized CT values ± SEM (n =
6, * denotes p < 0,05 by paired Students t-test).
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and the hyperproliferative effect was also observed on
purified naïve T cells. The aberrant TCR signaling is a
more likely candidate for the observed elevation in
proliferation.
Shb knockout CD4+ T lymphocytes displayed acceler-
ated levels of tyrosine phosphorylation under basal con-
ditions. Several signaling components, putatively Vav-1,
LAT and p38 MAPK, were markedly more phosphory-
lated in the absence of TCR activation. Stimulation-
independent signaling has been implicated as an impor-
tant factor in determining TCR signaling responsiveness
[45,46]. For instance, microRNA-181, a negative regula-
tor of several protein phophatases involved in TCR sig-
naling, causes increased basal signaling and a lowered
activation threshold when over-expressed [46]. The ele-
vated basal phosphorylation of important TCR pathway
targets in Shb knockout CD4+ T cells could make them
prone to respond quicker and more vigorously to a
given stimulus than their wild type counter parts.
Even though modifications in basal signaling might in
part explain the high proliferative rate displayed by Shb
knockout mice, the phosphorylation pattern of LAT is
also important to take into consideration. Shb and LAT
association, in response to TCR activation, has been
demonstrated in Jurkat cells [24], and mice expressing
the LATY136F mutant show a phenotype reminiscent of
the one present in the Shb knockout, with TH2 skewing
and lymphoproliferation [21,40]. As already mentioned,
a product probably corresponding to LAT (p36/38)
exhibited a high level of basal phosphorylation in Shb
null T cells, without becoming additionally phosphory-
lated by stimulation. LAT was originally identified as a
key adaptor protein in the TCR signaling cascade,
responsible for signals essential to T cell activation.
Recent studies have revealed that LAT is not only a
mediator of positive signals but also an important nega-
tive regulator of TCR signaling [47]. The defective sti-
mulation-induced LAT phosphorylation displayed by
Shb knockout T lymphocytes could result in a subopti-
mal assembly of the LAT signalosome. Consequently,
negative feedback loops acting on the TCR machinery
might be affected augmenting the proliferative response.
On the other hand, LATY136F mice have increased num-
bers of CD4+ memory cells [21,40], and as above men-
tioned, no such increase could presently be detected in
the Shb knockout.
The changes in peripheral CD4+ signaling resemble
those observed in the Shb knockout thymus. In Shb
knockout thymocytes Vav-1 displayed increased phos-
phorylation under basal conditions without any signs of
further amplified phosphorylation after TCR stimulation.
Cbl is a ubiquitin ligase that exerts a role in down- reg-
ulating ZAP70 activity upon TCR stimulation [48].
Since no difference in ZAP70 activity was noted upon
TCR stimulation between wild type and Shb knockout,
it seems unlikely that the altered Cbl phosphorylation
pattern observed plays any major role in affecting the
Shb knockout T cell phenotype. Instead the changes in
Cbl phosphorylation are probably a mere reflection of
the overall effects of Shb deficiency on the TCR signal-
ing complex.
T cell proliferation is dependent on TCR signaling
that in turn indirectly promotes cell division by activa-
tion of IL-2 transcription [38]. IL-2 production was,
however, normal in knockout cells despite the appear-
ance of an increased responsiveness to TCR stimulation
excluding this as an explanation for the Shb knockout
hyper-responsiveness.
In addition, Shb appears to affect more than prolifera-
tion, since the cytokine production was also different
from that observed in wild type T cells. Upon activation,
CD4+ T cells have the choice of maturing into different
classes of effector cells, each characterized by their own
cytokine profile. TH1 and TH2 cells are the two major
subsets, responsible for cellular and humoral immune
responses, respectively [39,49]. Signaling from the TCR
and cytokine receptors are of great importance in the
development of these effector cell responses. Alterations
in the activities of targets downstream of the TCR
might therefore also affect cytokine production. Vav-1
has for instance been demonstrated as an important fac-
tor in IL-4 production and the generation of a TH2
response. Vav-1 knockout mice preferentially develop a
TH1 response and Vav-1 in synergy with protein kinase
C-Θ (PKC-Θ) has been implicated in the promotion of
IL-4 transcription [50,51]. As already noted Shb knock-
out thymocytes as well as CD4+ T cells exhibited a
slight alteration in their Vav-1 activation. The increased
basal activity of Vav-1 in knockout cells may alter the
intracellular signaling conditions in favor of a TH2
response.
Moreover, the development kinetics of TH1 and TH2
cells are quite different. The hallmark cytokine of TH1
cells, IFN-g is produced within hours of activation.
Transcripts from typical type 2 cytokines such as IL-4
are on the other hand detected at the earliest on day 2
of stimulation in any significant amounts and a full-
fledged TH2 response can take weeks to develop [52,53].
The main reason for the slow development of TH2 cells
is thought to be the extensive chromatin remodeling
that is required to fully open the il4 gene locus for tran-
scription [54,55]. A critical part of the remodeling pro-
cess is cellular proliferation and it has even been
suggested that a certain number of cell divisions are
required before IL-4 transcription occurs [56]. Naïve
and unfractionated CD4+ T cells from Shb null mice
produce IL-4 more promptly after stimulation. Since
absence of Shb appeared to lead to an increased cell
Gustafsson et al. BMC Immunology 2011, 12:3
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division rate and faster cell cycle progression it may well
result in a more accessible il4 locus thus contributing to
a slight TH2 skewing in the immune system of Shb
knockout mice.
Conclusion
In the present work, we observe that CD4+ naïve T
lymphocytes lacking Shb exhibit increased proliferation
due to alterations in important TCR signaling pathways
also resulting in a bias towards developing a TH2 cyto-
kine response. Further studies of the effects of Shb on
the immune system may therefore prove useful in the
elucidation of TH2 driven pathologies such as allergies.
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